The present invention relates to the preparation of the optical isomer (R)-(+)-8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-napth[1,2,3-de]isoquinoline- . This invention also relates to the use of pharmaceutical compositions comprising (R)-(+)-8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-napth[1,2,3-de]isoquinoline for use for the treatment of movement disorders.

 
Web www.patentalert.com

< Method of treating myocardial infarction with PDE-5 inhibitors

< Azabicyclic heterocycles as cannabinoid receptor modulators

> Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient

> Pyrazolo[1,5-a]pyridines and medicines containing the same
~ 00282